{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for aminosalicylic root_notes_note in Note (approximate match)
Status:
Possibly Marketed Outside US
Source:
NDA022287
(1995)
Source URL:
First approved in 1992
Source:
NDA019651
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
M013
(2022)
Source URL:
First approved in 1989
Source:
M017
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
21 CFR 333D
(2015)
Source URL:
First approved in 1989
Source:
ANDA075576
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
M017
(1989)
Source URL:
First approved in 1989
Source:
M017
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
M020
(2015)
Source URL:
First approved in 1985
Source:
ANDA207459
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
NDA020353
(1976)
Source URL:
First approved in 1976
Source:
NDA020353
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
NCT01586338: Phase 4 Interventional Completed Osteoarthritis
(2012)
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Class:
POLYMER
Status:
Possibly Marketed Outside US
Class:
POLYMER
Status:
US Approved OTC
Source:
21 CFR 358.710(c)(1) dandruff:psoriasis coal tar
Source URL:
First marketed in 1921
Class:
STRUCTURALLY DIVERSE
